7
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Conventional Versus High-Dose Epidoxorubicin as Single Agent in Advanced Breast Cancer

, , , , , & show all
Pages 106-112 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hans Bäck, Anita Gustavsson, Staffan Eksborg & Stig Rödjer. (1995) Accidental Doxorubicin Overdosage. Acta Oncologica 34:4, pages 533-536.
Read now

Articles from other publishers (9)

Patrice Viens, Henri Roché, Pierre Kerbrat, Pierre Fumoleau, Jean-Paul Guastalla & Thierry Delozier. (2001) Epirubicin-Docetaxel Combination in First-Line Chemotherapy for Patients With Metastatic Breast Cancer. American Journal of Clinical Oncology 24:4, pages 328-335.
Crossref
R.L. Basser. (2001) Optimal dose of chemotherapy in adjuvant treatment of breast cancer. The Breast 10, pages 96-100.
Crossref
Yuuki Takamura, Yasuo Miyoshi, Tetsuya Taguchi & Shinzaburo Noguchi. (2001) Prediction of chemotherapeutic response by technetium 99m-MIBI scintigraphy in breast carcinoma patients. Cancer 92:2, pages 232-239.
Crossref
Kathy D. Miller, Nikhil Munshi, David Loesch, Lawrence H. Einhorn & George W. Sledge. (2000) A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma. Cancer 88:2, pages 375-380.
Crossref
Andrea Michelotti, Marco Venturini, Carmelo Tibaldi, Carmelo Bengala, Luigi Gallo, Flavio Carnino, Lucia Del Mastro, Rita Lionetto, Elda Montanaro, Riccardo Rosso & Pierfranco Conte. (2000) Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients. Breast Cancer Research and Treatment 59:2, pages 133-139.
Crossref
R.L. Dr. Basser, R. Abraham, L. Bik To, R.M. Fox & M.D. Green. (1999) Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer. Annals of Oncology 10:1, pages 53-58.
Crossref
P.F. Conte & A. Gennari. (1997) Anthracyclines-paclitaxel combinations in the treatment of breast cancer. Annals of Oncology 8:10, pages 939-943.
Crossref
M. Michael, G. C. Toner, I. N. Olver, A. Fenessy & J. F. Bishop. (1997) Phase I Dose Intensification Study of 2-Weekly Epirubicin with GM-CSF in Advanced Cancer. American Journal of Clinical Oncology 20:3, pages 259-262.
Crossref
J. A. Levi, M. H. Tattersall, J. M. Beith, D. Bell, R. D. Snyder & H. Wheeler. (2008) Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer. Australian and New Zealand Journal of Medicine 25:5, pages 474-478.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.